Dr. Priyanka Dutta Passecker

Priyanka is a biotechnology leader and entrepreneur with 18+ years of experience turning neuroscience, cell, gene, and regenerative medicine innovations into scalable, commercially viable products. Holding a PhD in Neuroscience from Trinity College Dublin, Ireland and dual Executive MBAs from WU Executive Academia, Austria and the Carlson School of Management, USA, she blends deep scientific expertise with strategic and commercial leadership. Priyanka’s track record spans CEO and Managing Director roles across Europe—including Co‑founder & CEO of Healiva SA and Managing Director & CEO of Neurolentech—along with global leadership positions at Novartis, UCB, Bioseutica, and Axol Bioscience. She also serves on boards and advisor for emerging Swiss and Austrian startups, including Juvion and TiliaHealth. She has scaled companies, secured international partnerships, unlocked funding, and led multimillion‑euro commercialization efforts across Asia, Europe, and the US. Recognized among Ernst & Young’s Entrepreneurial Winning Women (EMEIA), Priyanka also co‑founded the WU EA Female Leaders Network, one of Central Europe’s largest platforms for advancing women in leadership and advises the India–Austria Startup Bridge to foster cross‑border innovation.